​

Tempest Therapeutics (TPST) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Tempest Therapeutics Revenue Highlights

00

Tempest Therapeutics Revenue by Period

Tempest Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--100.00%
2017-12-31$295.00K-54.82%
2016-12-31$653.00K135.74%
2015-12-31$277.00K-97.15%
2014-12-31$9.73M100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31--

Tempest Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Tempest Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$486.00K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--100.00%
2018-12-31$3.56M6363.64%
2018-09-30$55.00K-32.10%
2018-06-30$81.00K20.90%
2018-03-31$67.00K-26.37%
2017-12-31$91.00K62.50%
2017-09-30$56.00K-33.33%
2017-06-30$84.00K33.33%
2017-03-31$63.00K-47.93%
2016-12-31$121.00K-38.58%
2016-09-30$197.00K4.23%
2016-06-30$189.00K29.45%
2016-03-31$146.00K-7.01%
2015-12-31$157.00K109.33%
2015-09-30$75.00K150.00%
2015-06-30$30.00K100.00%
2015-03-31$15.00K100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31--

Tempest Therapeutics generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Tempest Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MRSNMersana Therapeutics$40.50M$11.01M
FGENFibroGen$29.62M$1.08M
BRNSBarinthus Biotherapeutics$14.97M-
XLOXilio Therapeutics$6.34M$19.07M
INMBINmune Bio$14.00K-
OKUROnKure Therapeutics--
PDSBPDS Bio--
KZRKezar Life Sciences--
ALGSAligos Therapeutics-$965.00K
TPSTTempest Therapeutics--

TPST Revenue FAQ

What is Tempest Therapeutics’s yearly revenue?

Tempest Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. TPST's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Tempest Therapeutics’s quarterly revenue?

Tempest Therapeutics's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). TPST's quarterly revenue for Q4 2024 was $486K, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023).

What is Tempest Therapeutics’s revenue growth rate?

Tempest Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.